|
 BOSTON (AP) - Boston Scientific Corp. said Tuesday it's increasingly optimistic that it can quickly complete a $27 billion acquisition of troubled medical device maker Guidant Corp. while also fixing its own quality-control problems.
After reporting a higher fourth-quarter profit despite declining sales, Boston Scientific executives told analysts that the Guidant deal looks more appealing that it first did — in part because of a tax-law change Boston Scientific said Tuesday will cut its debt from the Guidant purchase by $900 million.
"The more we see, the better we like it, and the more opportunity we think we have," President and Chief Executive Jim Tobin said in a conference call.
|